Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Ion Beam Applications SA is a global leader in particle accelerator technology, specializing in the design, production, and marketing of innovative solutions for cancer diagnosis and treatment. Operating primarily through its Proton Therapy and Other Accelerators segment, the company develops medical and industrial particle accelerators, including proton therapy systems that deliver precise cancer treatments using proton beams, as well as cyclotrons for producing radioisotopes used in positron emission tomography and SPECT imaging. Its Dosimetry segment offers solutions to enhance efficiency and accuracy in radiation therapy and medical imaging quality assurance. Additional applications include industrial sterilization and ionization. Founded in 1986 and headquartered in Louvain-la-Neuve, Belgium, Ion Beam Applications SA employs around 2,000 people across more than 20 countries, including Belgium, the United States, Germany, and China. The company maintains strategic research partnerships, such as with SCK CEN for developing Actinium-225 isotopes, and innovations like ConformalFLASH technology. Certified as a B Corporation since 2021, it emphasizes sustainability through eco-design, renewable energy, and community initiatives, playing a pivotal role in advancing precision oncology and medical technology markets.
€16.10
€0.16 (-0.98%)
EOD Jun 23, 2026 · Twelve Data
Operating margin is thin at 3.58%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 24.5%, still solid.
At 38x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Negative free cash flow of -€38M. The business is consuming cash, not generating it.
38.3x earnings. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€620M
▲ +24.5% YoY
Net Income (TTM)
€13M
▲ +37.6% YoY
Op. Margin
3.58%
▲ +1.6pp YoY
ROIC
7.55%
▲ +3.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€38M
▼ -113.0% YoY
Op. Cash Flow (TTM)
-€29M
▼ -111.6% YoY
Net Debt
€52M
Cash & Equiv.
€65M
3Y CAGR: +19.7%
Continue Research
At a P/E of 38.3, Ion Beam Applications SA (IBAB.XBRU)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Ion Beam Applications SA scores 39/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 1.5%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Ion Beam Applications SA scores 39 out of 100 on Intrinsiqq's quality score, passing 2 of 7 checks, which makes it a lower-quality business on these measures. Recent fundamentals include a 3.6% operating margin and a 7.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
Yes, Ion Beam Applications SA pays a regular dividend of about €0.24 per share per year (typically in quarterly installments), a yield of roughly 1.5% at the current price. That is a payout ratio of about 55.4% of earnings, so the dividend is well covered. Ion Beam Applications SA has grown the dividend at roughly 5.1% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For IBAB.XBRU's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. you should weigh IBAB.XBRU's valuation and scores 39/100 on quality (lower-quality). It also yields about 1.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.